| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 2 securities · passive | ||||||
|
Precision BioSciences, Inc.
13G/A
DTIL · 74019P207
|
3.7% |
8/6/2025
Event 6/30/2025
|
||||
| Novartis Pharma AG | 3.7% | |||||
| Novartis AG | 3.7% | |||||
|
Erasca, Inc.
13G/A
ERAS · 29479A108
|
4.4% |
2/12/2025
Event 12/31/2024
|
||||
| Novartis Pharma AG | 4.4% | |||||
| Novartis AG | 4.4% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.